Dublin, Oct. 18, 2017 (GLOBE NEWSWIRE) -- The "Global Self Injection Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024" report has been added to Research and Markets' offering.

In this report, Global self-injection market is projected to reach USD 52.437.46 million by 2024 from USD 21.950.41 million in 2016, at a CAGR of 11.5% in the forecast period 2017 to 2024.

Major factors driving the growth of market are the rising cases of chronic diseases, increasing demand of self-injection devices.

The global self-injection market is segmented on the basis of product type, application, usage pattern, mode of administration, end user, distribution channel and geography:

• On the basis of product type, market is segmented into 4 types, namely, auto injectors, wearable injectors, needle free injectors (NFI), and pen injectors.
• On the basis of application, the global self-injection market is segmented into oncology, hormonal disorders, autoimmune diseases, orphan diseases, and others.
• On the basis of usage pattern the global self-injection market is segmented into curative care, immunization.
• Based on distribution channel, market is segmented into, Pharmacy stores, hospital pharmacy, direct tender and online pharmacy.
• Based on mode of administration, the global self-injection market is segmented into circulatory, organs, skin and central nervous system.
• On the basis of end user, the market is segmented into hospitals, clinics, home care settings, research laboratories and, pharma & biotech companies.

Market Dynamics

Drivers

• Rising Cases of Chronic Diseases
• Rising Demand of Self-Injection Devices
• Growth of Biologics Market
• Technological Advancements and Innovations in Drug Delivery Market

Restraints

• High Cost of Development
• Strict Regulatory Framework

Opportunity

• Increasing Demand for Generic and Biosimilar Drugs
• Generics
• Biosimilars
• Increasing Demand for Contraceptive Injectables
• Increasing Demand for Self-Administration of Drugs

Challenges

• Alternative Route of Drug Administration
• Product Recall
• Stability of Products
• Sterility of Injections

Becton, Dickinson and Company is going to dominate the global self-injection market following with, Novo Nordisk, Sanofi and Pfizer.

Key Topics Covered:

1. Introduction

2. Market Segmentation

3. Market Overview

4. Executive Summary

5. Premium Insights

6. Global Self-Injection Market, Regulatory

7. Global Self-Injection Market, Reimbusement

8. Global Self-Injection Market, by Type

9. Global Self-Injection Market, by Application

10. Global Self-Injection Market, by Usage Pattern

11. Global Self-Injection Market, by Mode of Administration

12. Global Self-Injection Market, by End User

13. Global Self-Injection Market, by Distribution Channel

14. Global Self-Injection Market, by Geography

15. Global Self Injection Market, Company Landscape

16. Company Profiles

• Elcam Medicalcompany Overview
• Bespak (Subsidiary of Consort Medical Company)
• Sanofi
• Sandoz International Gmbh
• Sandoz International Gmbh: Revenue Analysis
• Unilife Corporation
• West Pharmaceutical Services, Inc
• Pfizer Inc.
• Impax Laboratories, Inc.
• Penjet Corporation
• Crossject Needle-Free Injection Systems
• Wilhelm Haselmeier Gmbh & Co. Kg
• Antares Pharma
• Becton, Dickinson and Company
• Gerresheimer Ag
• Mylan N.V
• Novo Nordisk
• Owen Mumford Ltd
• Pharmajet
• SHL Group
• Ypsomed

For more information about this report visit https://www.researchandmarkets.com/research/sd7w57/global_self

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         Related Topics: Infusions and Injectables